Europe up in premarket on vaccine resilience hopes
Equities in Europe traded higher in the premarket on Thursday after Pfizer Inc. and BioNTech SE stated three doses of their vaccine against COVID-19 showed capability to neutralize the new strain of the virus, Omicron. As a precaution, England slightly tightened its restrictions aimed at curbing the spread of the disease, urging all businesses that can do so to switch to work from home.
Traders are now focusing on the forthcoming update on Germany’s trade balance, due for a release later this morning.
Both the DAX and the CAC 40 gained 0.09 at 7:22 am CET. At the same time, the FTSE 100 advanced by 0.08%. The euro lost 0.14% to the dollar to go for $1.13331 at 7:39 am CET, while the pound sterling declined by 0.08% to sell for $1.32144.
Get involved!
Comments